Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinically relevant end points and new drug approvals for myeloma.
Anderson KC, Kyle RA, Rajkumar SV, Stewart AK, Weber D, Richardson P; ASH/FDA Panel on Clinical Endpoints in Multiple Myeloma. Anderson KC, et al. Among authors: weber d. Leukemia. 2008 Feb;22(2):231-9. doi: 10.1038/sj.leu.2405016. Epub 2007 Nov 1. Leukemia. 2008. PMID: 17972944
Primary therapy of multiple myeloma with paclitaxel (taxol).
Dimopoulos MA, Arbuck S, Huber M, Weber D, Luckett R, Delasalle K, Alexanian R. Dimopoulos MA, et al. Among authors: weber d. Ann Oncol. 1994 Oct;5(8):757-9. doi: 10.1093/oxfordjournals.annonc.a058982. Ann Oncol. 1994. PMID: 7826909 Free article. Clinical Trial.
HyperCVAD for VAD-resistant multiple myeloma.
Dimopoulos MA, Weber D, Kantarjian H, Delasalle KB, Alexanian R. Dimopoulos MA, et al. Among authors: weber d. Am J Hematol. 1996 Jun;52(2):77-81. doi: 10.1002/(SICI)1096-8652(199606)52:2<77::AID-AJH2>3.0.CO;2-2. Am J Hematol. 1996. PMID: 8638645 Free article. Clinical Trial.
3,426 results